Brief: Chemometec A/S Reports 15% Revenue Growth For The First Half Of 2022/23

ChemoMetec A/S

08/02/2023 18:01

Feb 8 (Reuters) - Chemometec A/S  CHEMM.CO :
    * INTERIM REPORT 2022/23 - 15% REVENUE GROWTH AND DKK 145
MILLION
OPERATING PROFIT (+25%) FOR THE FIRST HALF FOLLOWING A
CHALLENGING SECOND QUARTER
    * GUIDANCE FOR EBITDA FOR FINANCIAL YEAR 2022/23 IS
MAINTAINED AT
DKK 245-260 MILLION
    * CURRENT GUIDANCE FOR 2022/23 FINANCIAL YEAR IS A REVENUE
OF DKK
430-460 MILLION
    * H1 EBITDA INCREASED 25% TO DKK 145.2 MILLION, AND EBITDA
MARGIN
WAS 60%

Source text for Eikon:  ID:nGNE4YgtN7 
Further company coverage:  CHEMM.CO 
 ((Reuters.Briefs@thomsonreuters.com;))